Skip to content
10-Q

Quarterly Report

Compass Therapeutics, Inc. CMPX

0001171843-25-007005

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 177.86M sh
Capex Q3 2025 · Sep 30, 2025 $25K
Capex Q3 2025 · Sep 30, 2024 $44K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$35.89M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$35.69M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $46.21M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $43.48M
Cash And Equivalents restated Q3 2025 · Sep 30, 2024 $19.4M
Stockholders Equity Q3 2025 · Sep 30, 2025 $209.61M
Stockholders Equity Q3 2025 · Jun 30, 2025 $93.21M
Stockholders Equity Q3 2025 · Mar 31, 2025 $110.28M
Stockholders Equity Q3 2025 · Dec 31, 2024 $125.23M
Stockholders Equity Q3 2025 · Sep 30, 2024 $138.4M
Stockholders Equity Q3 2025 · Jun 30, 2024 $146.1M
Stockholders Equity Q3 2025 · Mar 31, 2024 $157.06M
Stockholders Equity Q3 2025 · Dec 31, 2023 $148.54M
Current Liabilities Q3 2025 · Sep 30, 2025 $12.41M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.87M
Total Liabilities Q3 2025 · Sep 30, 2025 $21.65M
Total Liabilities Q3 2025 · Dec 31, 2024 $15.17M
Current Assets Q3 2025 · Sep 30, 2025 $221.12M
Current Assets Q3 2025 · Dec 31, 2024 $132.75M
Total Assets Q3 2025 · Sep 30, 2025 $231.26M
Total Assets Q3 2025 · Dec 31, 2024 $140.4M
Eps Basic Q3 2025 · Sep 30, 2025 −$0.08
Eps Basic Q3 2025 · Sep 30, 2025 −$0.34
Eps Basic Q3 2025 · Sep 30, 2024 −$0.08
Eps Basic Q3 2025 · Sep 30, 2024 −$0.25
Sga Expense Q3 2025 · Sep 30, 2025 $2.99M
Sga Expense Q3 2025 · Sep 30, 2025 $12.55M
Sga Expense Q3 2025 · Sep 30, 2024 $3.63M
Sga Expense Q3 2025 · Sep 30, 2024 $11.6M
Rd Expense Q3 2025 · Sep 30, 2025 $12.83M
Rd Expense Q3 2025 · Sep 30, 2025 $42.3M
Rd Expense Q3 2025 · Sep 30, 2024 $8.61M
Rd Expense Q3 2025 · Sep 30, 2024 $29.3M
Net Income Q3 2025 · Sep 30, 2025 −$14.26M
Net Income Q3 2025 · Sep 30, 2025 −$50.77M
Net Income Q3 2025 · Jun 30, 2025 −$19.88M
Net Income Q3 2025 · Mar 31, 2025 −$16.63M
Net Income Q3 2025 · Sep 30, 2024 −$10.48M
Net Income Q3 2025 · Sep 30, 2024 −$34.34M
Net Income Q3 2025 · Jun 30, 2024 −$13.08M
Net Income Q3 2025 · Mar 31, 2024 −$10.79M
Operating Income Q3 2025 · Sep 30, 2025 −$15.82M
Operating Income Q3 2025 · Sep 30, 2025 −$54.85M
Operating Income Q3 2025 · Sep 30, 2024 −$12.24M
Operating Income Q3 2025 · Sep 30, 2024 −$40.05M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $850K
Shares Diluted Q3 2025 · Sep 30, 2024 137.6M sh
Shares Diluted Q3 2025 · Sep 30, 2024 137.3M sh